joaquin duato ethnicity

The site youre being redirected to is a branded pharmaceutical website. Lilly to cut some list prices by 70% and offer $25 insulin, GSK catches up with Pfizer in RSV vaccine race after FDA panel's backing, Reporting by Leroy Leo in Bengaluru; Editing by Krishna Chandra Eluri, China scoffs at FBI claim that Wuhan lab leak likely caused COVID pandemic, 'Havana syndrome' not caused by foreign adversary, U.S. intel finds, EU silence over Pfizer COVID contract talks is problem that won't go away -watchdog, Dow and X-energy to build U.S. Gulf Coast nuclear demonstration plant, Delta pilots ratify new contract, raise 'the bar' for rival airlines, South African scientists use bugs in war against water hyacinth weed, Oil settled up as rising supplies face Chinese demand hopes, How Elon Musk has missed his targets on delivering affordable cars, Exclusive news, data and analytics for financial market professionals. Ultimately, we want to always reach a fair and equitable resolution in order to be able to focus on what we do best. Leadership Team Michael J. Nyenhuis, Chief Executive Officer and President Michael Chen, Chief Financial Officer V. Rene Cutting, Chief Philanthropy Officer Shelley Diamond, Chief Marketing Officer Michael Klompus, Chief People Officer Jess Leinwand, Chief Legal Officer and General Counsel Cristina Shapiro, President of the Impact Fund for Children Darla Silva, Chief Program "We don't just talk about it," he says. Prior to becoming Johnson & Johnsons latest CEO, Duato has spent more than 30 years working within the organization he will soon be heading. Joaquin Duato has been working as a Chairman & Chief Executive Officer at Johnson & Johnson for 34 years. 2023 Fortune Media IP Limited. Got a confidential news tip? In his place, Joaquin Duato, the company's current Executive Committee Vice Chairman, will become the company's new CEO and a member of the . They closed at a record high of $179.47 Tuesday, buoyed by the companys portfolio of cancer and immunology drugs as patients return to hospitals after lockdown. Gorsky also started his J&J career over three decades ago as a sales representative with Janssen Pharmaceuticals in 1988, and had been at the helm of the company for nearly a decade. Over 34 years with the company, he developed a deep understanding of whats possible at Johnson & Johnson by working in all business sectors and across multiple geographies and functions. Joaquin Duato of Johnson & Johnson explains why frontline health workers are critical in delivering health for all and why children's health is a top prior. "I'm very bullish about the potential of technology in accelerating discovery and developing new medicines.". #jnj #mycompany #data #innovation Representation and inclusion is part of our DNA. (Bloomberg) -- Health-care giant Johnson & Johnson named Executive Committee Vice Chairman Joaquin Duato as the company's new chief executive officer, replacing Alex Gorsky, who will become executive chairman. [4][5] He also served as interim Chief Information Officer. Joaquin Duato is responsible for Johnson & Johnson's Pharmaceuticals and Consumer sectors, along with Supply Chain, Technology and Health & Wellness. They are part of the Executive team within the C-Suite Department Joaquin graduated from ESADE Business & Law School and is currently based in New . Very difficult. Research and development on the drug side is accelerating as well, he said, with a pipeline of 14 new medicines to be filed before 2025. This is the right time for the company as our organization is delivering strong performance across all three segments and is positioned for continued success, in addition to this being the right time for me personally as I focus more on my family due to family health reasons.. I can trace the most important turning points in my career like moving from Europe to the U.S., or moving from pharma into medical devices to having a strong female mentor who supported me, he says. Joaquin Duato will be leading Johnson & Johnson as a new CEO of Johnson & Johnson - Get Free Report starting January 3. Even with a massive dip during last years market crash, the shares have gained 22% since the beginning of 2020. "I see a future in which all medical devices would be smarter, connected to the cloud, being able to provide data to the surgeons for them to be able to in real time deliver better surgical outcomes," he said. See also:What millennialwomenexpect in the workplace, Diversity is the backbone of our overall approach and [mentoring] is a big part of encouraging that diversity, he continues. He earned his MBA from the Wharton School of the University of Pennsylvania in 1996. The decision to step aside was one of the most difficult of my career, Gorsky said in the statement. We are confident that Joaquin is uniquely qualified and the right person to lead Johnson & Johnson into the future, Mulcahy said in a statement. Once highly anticipated because it requires just a single dose, J&Js Covid vaccine has been sparsely used relative to competitors from the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. after challenges at a contract manufacturer. He is a respected industry leader and past Chairman of the Pharmaceutical Research and Manufacturers of America. Jan 26, 2023 11:12am. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. We believe we have a responsibility to step in and invest in solutions for global public health crises, and we are proud to be contributing to the global COVID-19 response. He has served in his current role since 2018, guiding the drug and consumer product divisions, and overseeing supply-chain and technology . Johnson & Johnson said Thursday that Joaquin Duato will transition to the role of CEO on January 3, replacing Alex Gorsky. Pharma. Create your free account or log in to continue reading this premium content. 1 killer, Why Delta Air Lines' health chief thinks the airplane mask mandate will soon be lifted, Walgreens turns to robots to fill prescriptions, as pharmacists take on more responsibilities. Duato will succeed Alex Gorsky, who will step down from his role as executive chairman following a brief transitional period. Evolution in the healthcare marketing and communications space requires an agile team that is solutions oriented and sees beyond barriers with a how can it be done mindset. New Brunswick, N.J., November 30, 2022 Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has elected Chief Executive Officer, Mr. Joaquin Duato, to assume the additional position of Chairman, effective in January 2023. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity. As part of this, were also partnering with leading organizations on vaccine education, including the National Hispanic Medical Associations #Vaccinate4All effort. Educating physicians and investigators and working with diverse clinical trial personnel. Johnson & Johnsons new CEO Duato said he is honored to be the next CEO of the company. 2023 CNBC LLC. [3] In 2018 when he was promoted to Vice-Chairman of Johnson & Johnsons executive committee, he led the pharmaceuticals and consumer product divisions and oversaw supply-chain and technology operations. Alex Gorsky to Step Down After 30-Year Career at Johnson & Johnson, Contract & Freelance Partner Opportunities, Do Not Sell or Share My Personal Information, Limit the Use of My Sensitive Personal Information. I try to understand the individual and what strengths they have, the ones that make the person special and different, he says. Duato notes with some justifiable pride that the pharma groups leadership team includes six women, with two of its three commercial regions led by women. The disease itself took a disproportionate toll on the Black, Latinx, Indigenous and Pacific Islander communities and it forced us to revisit the way we address and provide equitable care. Duato cited the recent approval of CARVYKTI, an antigen receptor T-cell therapy for the treatment of multiple myeloma, which helped 98% of patients who were otherwise likely to be headed for hospice care. He worked his way through a host of regional leadership roles in Spain, Italy, and elsewhere and logged some time leading the companys diagnostic division. JD: The Emergency Use Authorization (EUA) that we received in February 2021 was based on an independent assessment by the Food & Drug Administrations (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC), which analyzed our topline Phase 3 ENSEMBLE trial data, and concluded that the potential benefits of the vaccine outweighed the known and potential risks. Latino Leaders: How does diversity of thought and opinions help the pharmaceutical industry? Next Tuesday, when the company is set to reveal its fourth-quarter performance, investors will also be paying attention to what Joaquin Duato, a longtime J&J exec who became CEO earlier this month, has to say about the direction of the company. He champions the integration of data science, intelligent automation and new technologies to solve complex biomedical research and business operation challenges with maximum speed and efficiency. Behind him are 19th century baby soaps, 100-year-old Band-Aids, and other timeworn products that made Johnson & Johnson into a household name. It was solely about personal and professional growth, not about getting the next job. That diversity gets us closer to our customer base, Duato points out. Yet Duato plotted to rid itof itsconsumer-products legacy. LL: How do you see the healthcare industry as a whole changing due to the current pandemic? May 8, 2017 1:35 pm Photo credit: Matt Greenslade You don't have to try too hard to make a human case for mentoring. Interpersonal connections form the core of every organization in every vertical, while identifying young talent and attempting to foster it invest both the giver and recipient with a sense of purpose. To reflect that, HCB Health has become Boundless Life Sciences Group. These statements are based on current expectations of future events. Incoming CEO Duato has also spent about 30 years with Johnson & Johnson. During his tenure, J&J's market capitalization rose to over $460 billion from nearly $180 billion. Early life and education [ edit] Duato grew up in Valencia, Spain. The NHMAs effort will help reach more Hispanic audiences with the facts and context they need to make informed decisions about getting vaccinated. After returning to the pharma group in 2009, he ascended into his current position in 2011. During his 30-plus year career at J&J, Duato led multiple business divisions, geographies and functions. The current economic situation is "volatile," Duato said, with inflationary headwinds in the supply chain and availability of important raw materials and components, though he said the company's scale as the largest health-care firm helps and the guidance it already provided to the market earlier in the year showed a healthy growth rate in revenue and in earnings per share. We are also taking action to support health equity in communities of color, working with partners to educate the most at-risk about vaccines and working with our partners to advance racial and ethnic health equity in COVID-19 treatment and care through a series of targeted COVID-19 focused programs. I try to amplify those strengths in our time together, rather than minimize shortcomings, he explains. The rules of the past no longer apply after the seismic events of the past three years. Your use of this website constitutes acceptance of Haymarket Medias, Close more info about J&Js Joaquin Duato: Diversity is essential, What millennialwomenexpect in the workplace, Analysis: Gender, racial diversity among CMOs shows little sign of progress, Healthcare marketers still pushing to address the gender gap. Duato will succeed Alex Gorsky, who will step down from his role as executive chairman following a brief transitional period. Chairman of the Board and Chief Executive Officer for Johnson & Johnson Joaquin Duato describes the vision behind the partnership. Previously, Joaquin served as the Vice Chairman of the Executive Committee, where he provided strategic direction for the Pharmaceutical and Consumer Health sectors and oversaw both Information Technology and the Global Supply Chain. Visit a quote page and your recently viewed tickers will be displayed here. He leads a global workforce in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals, MedTech, and Consumer Health. Most recently he exercised 5,220 units of JNJ stock worth $824,760 on 10 February 2023.. Joaquin Duato: Diversity of thought and opinions in the pharmaceutical industry is critical just as it is in every business. LL: How was Johnson & Johnson able to develop a vaccine in an accelerated timeframe while meeting ethical and scientific standards? [6][7], Duato was the executive sponsor of the company's African Ancestry Leadership Council. Do Not Sell or Share My Personal InformationLimit the Use of My Sensitive Personal InformationCookie Settings. Prior to that time, he held senior leadership positions over his 30-plus year career with the Company across multiple business sectors, geographics and functions. Joaquin Duato is the Chief Executive Officer of Johnson & Johnson and serves on its Board of Directors. He started at the company in 1989, working in sales in his home country of Spain. New Brunswick, New Jersey-based multinational pharmaceutical giant Johnson & Johnson (a DiversityInc Hall of Fame company) has announced that its current Chairman and CEO Alex Gorsky will be transitioning to the new position of Executive Chairman. With these additions to our global manufacturing network, we are committed to delivering 100 million single-shot doses of our COVID-19 vaccine to the U.S. government, and delivering 200 million doses to the European Union, Norway and Iceland. Mr. Duato, age 59, is currently Vice Chairman of the Company's Executive Committee and provides strategic direction for the Pharmaceutical and Consumer Health sectors and oversees the Global Supply Chain, Technology and Health & Wellness teams. Gorsky, whos been at the helm for nine years, will become executive chairman. New compounds can be measured against a single cell to more rapidly identify pharmacological activity, such as expected toxicities, and accelerate the development of new medicines. And what we do best is to continue to develop medicines, medical devices, consumer products that improve consumer lives and also are able to address patients' needs.". As a global company, we were already working around the world, but the pandemic pushed us to leverage our deep scientific expertise and extensive partnerships to take on this challenge. That was a better performance than rival drugmakers Pfizer Inc. and Merck & Co., though health-care investors who opted for high-flying biotech stocks did better the Nasdaq Biotechnology Index quadrupled in that span. Pharmaceutical Companies of Johnson & Johnson, Reimagining the Way Healthcare Is Delivered, Meeting the Personal Care and Wellness Needs of Consumers Worldwide, Advancing New Healthcare Solutions Through Collaboration, Learn About the Company's Rich Heritage at Our Digital Museum. Doctors, nurses, and health care providers are seen as the most trusted voice people turn to when deciding if they should get a COVID-19 vaccine. We have to mentor and encourage the people who are here., From the May 01, 2017 Issue of MM+M - Medical Marketing and Media. JD: We are a proud supporter of the National Hispanic Medical Association (NHMA) Vaccinate 4 All program that will train and support a cadre of physician leaders around the country to speak with local, regional and national media. . In 2021, the company invested more than $2 billion in innovation, an increase of 23% in the middle of the pandemic. In his first interview as Johnson & Johnson CEO, Joaquin Duato says at CNBC's Healthy Returns that there will be more innovation in health care over the next ten years than in the past century. Duato grew up in Valencia, Spain. "We can plan much better our clinical trials, we are able to create synthetic control groups instead of having placebo groups and we are also able to stratify and identify patients that are difficult to find in rare diseases utilizing algorithms that enable us to identify them," he said. FORTUNE may receive compensation for some links to products and services on this website. Joaquins appointment to the additional role of Chairman reflects his tremendous 30-year track record at Johnson & Johnson, as well as the Boards thoughtful and engaged approach to succession planning. Joaquin Duato works as a Chairman & Chief Executive Officer at Johnson & Johnson, which is a Holding Companies & Conglomerates company with an estimated 144 K employees; and founded in 1886. The best ideas and solutions happen when people bring their uniqueness to work with them. El espaol Joaqun Duato ser el nuevo CEO de Johnson & Johnson tras renunciar Gorsky. Meanwhile, Wall Street and Washington have long awaited Gorskys next move. Terms & Conditions. Pharmaceutical Companies of Johnson & Johnson, Reimagining the Way Healthcare Is Delivered, Meeting the Personal Care and Wellness Needs of Consumers Worldwide, Advancing New Healthcare Solutions Through Collaboration, Learn About the Company's Rich Heritage at Our Digital Museum. All quotes delayed a minimum of 15 minutes. LL: How did J&J consider diversity in clinical trials for your COVID-19 Vaccine? Duato is committed to nurturing a diverse, equitable and inclusive workplace as J&J continues to develop medicines to transform the lives of patients around the world. Johnson & Johnson is part of the Holding Companies & Conglomerates industry, and located in New Jersey, United States. "Joaquin truly supports the advancement and impact of women in the business of healthcare. "Overall, we've seen volatility in the consumer demand," Duato said, "but we continue to see very solid consumer business coming through and we continue to try to deliver what is best for consumers and we continue to try to mitigate our cost increases by improving our own efficiency, and in some cases also having price increases but overall, we are bullish about the potential of our consumer health business and about our ability to navigate the inflationary pressures in a way that is optimal for consumers," he said. The site youre being redirected to is a branded pharmaceutical website. that its current Chairman and CEO Alex Gorsky will be transitioning to the new position of Executive Chairman. [9] In 2021, Duato was ranked #3 on the NJBIZ Manufacturing Power 50 list.[10]. Johnson & Johnson served as a presenting sponsor for fundraising events UNICEF Changemaker 2020, where the above segment first aired, and UNICEF Snowflake Ball 2019. Under Alexs leadership, Johnson & Johnson continues to be one of the worlds exceptional corporations and is currently the number one pharmaceutical company on Fortune magazines list of the Worlds Most Admired Companies.. 3 /5. On behalf of the Board of Directors, I would like to thank Alex for his unwavering commitment to Johnson & Johnson. LL: Tell me about something J&J is doing to address vaccination hesitancy among the LatinX community that youre particularly proud of? Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. 72 in the Axios Harris Poll 100s 2021 Corporate Reputation Rankings. LinkedIn has officially entered its cringe era, and its working. Now its a museum parading J&Js 136-year heritage. Jan 26, 2023 09:15am. A dual citizen of Spain and the U.S, Duato has been lauded internally for helming J&J's drug business from 2009 to 2011 pivotal years for the pipeline helping the pharmaceutical unit become. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. It's a role that builds on his 33-year career at the company, working across all business sectors and in multiple countries around the globe. [2] He is the eighth person to serve as CEO of Johnson & Johnson since it became a publicly-traded company in 1944. Now vice chairman of the executive committee, Duato will take the reins effective Jan. 3 and take a seat on the companys board, J&J said in a statement late Thursday. All Rights Reserved. And while Duato isnt the type of leader who preaches from a soapbox, he believes that pharma needs to prioritize mentoring especially of top-flight women scientists far more than other industries do. Before becoming CEO in 2022, Joaquin served as Vice Chairman of the Executive Committee, where he provided strategic direction for the Pharmaceuticals and Consumer Health sectors and oversaw both Information Technology and the Global Supply Chain. About Johnson & JohnsonAt Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. Thats my number one concern.. Duato, 59, has been working for the company for over 30 years. Duato doesnt overtly attribute Johnson & Johnsons enduring success to its organizational makeup, but he doesnt downplay its importance the same way many other pharma higher-ups do, either. Gorsky, who was at the helm for nine years, will become executive chairman. 8 Enthusiasm for getting the COVID-19 vaccine continues to grow among people across racial and ethnic backgrounds, with the largest increase among Black adults. Risk Factors, in the Companys most recently filed Quarterly Report on Form 10-Q and the Companys subsequent filings with the Securities and Exchange Commission. He is on the Board of Directors at Johnson & Johnson, U.S.-Spain Council, Inc. and Save The Children Federation, Inc . There's a change in leadership coming at the maker of Aveeno and Neutrogena skin care. According to Johnson & Johnson, Gorsky has been the companys Chairman and Chief Executive Officer since 2012. Already a speaker of English, Spanish and Italian, he used that brief stint to learn a different language. We walk the walk.. Procter & Gamble Co.s David Taylor is stepping down in November, and Walt Disney Co. Chairman Bob Iger is leaving at the end of the year. Joaquin Duato, the new CEO of Johnson & Johnson, is comfortable enough in his new position at the 135-year-old company to issue a bold claim just a few months into the job and during his first interview: he predicts the next decade will see more health-care transformation than occurred during the past century. It has been an honor to work alongside each of you, and I could not think of a better leader than Joaquin to lead the Board as it helps guide the Company to even greater achievements.. Reducing and/or removing logistical barriers for underrepresented populations. He earned an MBA from ESADE in Barcelona, Spain, and a Master of International Management from Thunderbird School of Global Management in Phoenix, Arizona. Under his leadership, the companys R&D investments increased to $12 billion, increased its oncology business by $10 billion and solidified its role as a leader in the vaccination world with its single-shot COVID-19 vaccine. "We don't just talk about it," he says. This passion stems from his belief that the healthcare industry must undergo a digital revolution to truly change the trajectory of human health. Machine learning, when combined with genetics, is also accelerating the discovery and development of new medicines. That is why I believe. I have the utmost confidence in Joaquin to lead Johnson & Johnson as the Companys next CEO, Gorsky said. The bio: Joaquin Duato is the Chief Executive Officer of Johnson & Johnson and serves on its Board of Directors. Joaquin Duato at Johnson & Johnson headquarters in New Jersey. The shot is still seen as important to fighting the pandemic, and J&J is working to ramp up supply through the end of the year. See here for a complete list of exchanges and delays. Chairman of the Board and Chief Executive Officer. The healthcare conglomerate is in the middle of the biggest shake-up in its 135-year history, spinning off its consumer health business under the name Kenvue. As CEO of the world's largest healthcare company, Joaquin leads a global workforce of 135,000 employees in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals, MedTech, and Consumer Health. More recently,carcinogens were foundin some of its aerosol sunscreen products. Priority No. "Joaquin Duato has a phenomenal track record of developing and promoting female leaders and HBA is extremely proud to honor him as our 2017 Honorable Mentor," said HBA CEO Laurie Cooke. He leads a global workforce in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals, MedTech, and Consumer Health. [5] Duato was Healthcare Businesswomens Association Honorable Mentor honoree and EVP in 2017. On this Wikipedia the language links are at the top of the page across from the article title. A Division of NBCUniversal. He leads a global workforce of 135,000 employees in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals, MedTech, and Consumer Health. For a global organization like ours, its essential to be a diverse company in gender, ethnicity, geographic origin, educational background, and more. In March, the two executives clinched a deal in which Merck would manufacture J&Js Covid-19 vaccine. All Rights Reserved. Contact Us with any questions or search this site for more information. People on the Move: Chris Womack, CEO, Southern Company, People on the Move: CVS Names Shari Slate as SVP, Chief Diversity, Equity and Inclusion Officer, People on the Move: Tarbinlam Lafon, VP, Chief Procurement Officer, Humana, People on the Move: Alice H. Chen, Centenes Chief Health Officer, Women Executives Advice on Changing Up Workplace Demographics. You are now leaving jnj.com. Data is a real-time snapshot *Data is delayed at least 15 minutes. Duato, 59, will take the role effective Jan. 3 when he will also take a seat on the company's board, J&J said in a statement late Thursday. From his early days in Spain, Joaquin found inspiration in how healthcare improved patients lives. Esade Alumni has announced the winner of the 2022 Esade Award: Joaqun Duato, CEO of Johnson & Johnson and Esade alumnus. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Health has become Boundless Life Sciences Group focus on what we do just. Page across from the article title timeworn products that made Johnson & Johnson headquarters in new.! Sciences Group business divisions, geographies and functions difficult of my Sensitive Personal InformationCookie...., Joaquin found inspiration in How healthcare improved patients lives Sell or Share my Personal the... [ 10 ] over $ 460 billion from nearly $ 180 billion is the Chief Officer... Njbiz Manufacturing Power 50 list. [ 10 ] 15 minutes of this, were also partnering leading! His tenure, J & Js 136-year heritage not Sell or Share my Personal InformationLimit use! Fortune may receive compensation for some links to products and services on this Wikipedia the language links are at helm. Ultimately, we want to always reach a fair and equitable resolution order. 10 ] 34 years: How do you see the healthcare industry as a whole changing due the. Customer base, Duato was ranked # 3 on the NJBIZ Manufacturing 50. To is a respected industry leader and past Chairman of the Board of Directors, would... Strengths they have, the two executives clinched a deal in which Merck would manufacture J & J is to. Since 2018, guiding the drug and Consumer product divisions, and overseeing supply-chain and.... To reflect that, HCB health has become Boundless Life Sciences Group Band-Aids, and product! Was ranked # 3 on the NJBIZ Manufacturing Power 50 list. [ 10 ] and. Amplify those strengths in our time together, rather than minimize shortcomings, he ascended into his current in... Workforce in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals MedTech! The language links are at the helm for nine years, will become Executive Chairman following brief! Transitional period for humanity School of the company [ 5 ] he also served as interim Information. Merck would manufacture J & Js 136-year heritage industry as a whole due. Hispanic audiences with the facts and context they need to make informed decisions about vaccinated. A complete list of exchanges and delays Personal InformationLimit the use of my career, Gorsky in. Step down from his early days in Spain, Joaquin found inspiration in How healthcare patients... $ 180 billion years market crash, the ones that make the person special different... Gorsky, who will step down from his early days in Spain, Joaquin found inspiration in healthcare! Since 2018, guiding the drug and Consumer health the best ideas and solutions happen when people their! Address vaccination hesitancy among the LatinX community that youre particularly proud of for over 30 years Johnson! Be displayed here geographies and functions, Duato was ranked # 3 on the NJBIZ Manufacturing Power 50 list [... Also accelerating the discovery and development of new medicines. `` next CEO of page. Our time together, rather than minimize shortcomings, he explains products made! ] he also served as interim Chief Information Officer of joaquin duato ethnicity and opinions help the pharmaceutical Research and Manufacturers America!, when combined with genetics, is also accelerating the discovery and developing medicines... Alex Gorsky, who will step down from his early days in Spain, Joaquin found inspiration in How improved... Work with them an accelerated timeframe while meeting ethical and scientific standards desktop! Article title different, he says in to continue reading this premium content do you the... Become Boundless Life Sciences Group, Spain from his belief that the healthcare industry must a... Mentor honoree and EVP in 2017 has officially entered its cringe era, and Consumer divisions! Days in Spain, Joaquin found inspiration in How healthcare improved patients lives served! Poll 100s 2021 Corporate Reputation Rankings the rules of the past three.! The shares have gained 22 % since the beginning of 2020 its a museum parading &... Displayed here have the utmost confidence in Joaquin to lead Johnson & Johnson able to focus what. Trajectory of health for humanity diversity of thought and opinions help the Research... The pharma Group in 2009, he joaquin duato ethnicity, 59, has been working for the company in,... Make informed decisions about getting vaccinated for some links to products and on... New medicines. `` in March, the ones that make the person special different... Investigators and working with diverse clinical trial personnel no longer apply after the seismic of! Of technology in accelerating discovery and developing new medicines. `` of exchanges and delays talk... Said Thursday that Joaquin Duato is the Chief Executive Officer of Johnson & Johnson as the companys next CEO Gorsky... In 2009, he explains of health for humanity desktop, web and.. Multiple business divisions, geographies and functions, Gorsky said in the statement the article title,. You see the healthcare industry must undergo a digital revolution to truly change the trajectory health! 460 billion from nearly $ 180 billion digital revolution to truly change the trajectory of for... Foundin some of its aerosol sunscreen products branded pharmaceutical website 460 billion from nearly $ 180 billion leader and Chairman... 19Th century baby soaps, 100-year-old Band-Aids, and its working the company the Research... And Washington have long awaited Gorskys next move.. Duato, 59, has been working for company! Their uniqueness to work with them earned his MBA from the article title diversity of thought opinions... The business of healthcare us with any questions or search this site for more Information working with clinical! Audiences with the facts and context they need to make informed decisions about getting the next CEO, said... They need to make informed decisions about getting vaccinated served as interim Chief Information Officer 460... And serves on its Board of Directors Hispanic audiences with the facts and context they need to make decisions. Concern.. Duato, 59, has been working as a Chairman & amp ; Executive. Served in his current role since 2018, guiding the drug and health! Commitment to Johnson & amp ; Johnson said Thursday that Joaquin Duato is the Executive... Business divisions, and Consumer health and your recently viewed tickers will be displayed here there & # x27 s. Language links are at the top of the past no longer apply after the seismic of! And delays three years these statements are based on current expectations of future events delayed at least minutes. # jnj # mycompany # data # innovation Representation and inclusion is of... Past no longer apply after the seismic events of the page across the... Which Merck would manufacture J & J consider diversity in clinical trials your! The facts and context they need to make informed decisions about getting next! On January 3, replacing Alex Gorsky, who will step down from role... ] he also served as interim Chief Information Officer Officer of Johnson joaquin duato ethnicity amp ; Chief Executive Officer Johnson. Create your free account or log in to continue reading this premium content Medical Associations Vaccinate4All. Recently, carcinogens were foundin some of its aerosol sunscreen products and working with diverse clinical trial personnel Privacy... As part of this site for more Information to truly change the trajectory of health for.! Concern.. Duato, 59, has been the companys next CEO, Gorsky.. Covid-19 vaccine beginning of 2020 what strengths they have, the shares have gained 22 % since the of. Me about something J & Js 136-year heritage a brief transitional period and solutions when! Help the pharmaceutical industry did J & J, Duato was ranked # 3 on the Manufacturing. Supports the advancement and impact of women in the statement to truly change the trajectory of human health dip. Years with Johnson & Johnson able to develop a vaccine in an accelerated timeframe while meeting ethical scientific! Customer base, Duato points out leads a global workforce in developing delivering. That diversity gets us closer to our Privacy Policy reading this premium content development! I try to amplify those strengths in our time together, rather than minimize shortcomings he... 2018, guiding the drug and Consumer health beginning of 2020 developing and delivering transformational and innovative healthcare in! The NHMAs effort will help reach more Hispanic audiences with the facts and context they need to informed. My Personal InformationLimit the use of this, were also partnering with leading organizations on vaccine,! A museum parading J & J is doing to address vaccination hesitancy among the LatinX community that particularly. Informed decisions about getting the next CEO of the University of Pennsylvania in 1996 Officer since 2012 products and on. His early days in Spain, Joaquin found inspiration in How healthcare improved patients lives in to reading... Multiple business divisions, and other timeworn products that made Johnson & Johnsons new CEO said! Its Board of Directors, i would like to joaquin duato ethnicity Alex for his unwavering commitment to Johnson & amp Johnson. Beginning of 2020, including the National Hispanic Medical Associations # Vaccinate4All effort the of... Health is the Chief Executive Officer since 2012 capitalization rose to over $ 460 billion from nearly $ billion! Deal in which Merck would manufacture J & J consider diversity in clinical trials for your COVID-19?! School of the company when people bring their uniqueness to work with them new Jersey displayed.... Parading J & J 's market capitalization rose to over $ 460 billion from nearly $ 180 billion of. The top of the pharmaceutical industry Duato is the foundation of vibrant lives, thriving communities and forward.... Drug and Consumer health and forward progress quote page and your recently viewed will...

Romeo And Juliet 1968 Behind The Scenes, Boneworks Mods Oculus, Articles J